Biomet closes Lanx acquisition of spinal implant maker; Report: Robotic surgery problems underreported;

@FierceMedDev: Sequenom vows to appeal court decision invalidating prenatal test patent. More | Follow @FierceMedDev

@MarkHFierce: PerkinElmer said the government shutdown could, in part, affect revenue projections for the year. ICYMI yesterday | Follow @MarkHFierce

@MichaelGFierce:  | Follow @MichaelGFierce

> Robotic surgical systems are causing problems, but issues are either reported late to the FDA, inaccurately or not at all, a new study concluded. Story

> Biomet said it has closed its acquisition of Lanx, a venture-backed maker of FDA-cleared spin fusion systems. Item

> Moog ($MOG.A) reported $15.6 million in fourth quarter earnings, down from $41.8 million last year, due to impairment charges on medical devices and restructuring. Story

> Nuance Communication plans to launch new technology for doctors that will turn mobile phones into virtual assistants that understand clinical language. Story

> Silex Medical, a maker of laparoscopic surgical instruments, will be both hurt and helped by the Affordable Care Act. Story

Biotech News

@FierceBiotech: Popular yesterday: Feds launch probe of AstraZeneca's controversial late-stage Brilinta study. Article | Follow @FierceBiotech

@JohnCFierce: NovaQuest lands $459M fund for goal-line dealmaking--That's $1.2B for today. More | Follow @JohnCFierce

@DamianFierce: GlobeImmune pulls plug on $75M IPO despite still-bubbling market. Article | Follow @DamianFierce

@EmilyMFierce: Scripps Research scientists reach major milestone w/ HIV research, paving wave for new vaccine efforts. FierceBiotech Research story | Follow @EmilyMFierce

> Flailing Ariad swallows poison pill to fend off takeovers. More

> VC OrbiMed hauls in $735M fund in 'vibrant' time for biotech. News

> NovaQuest lands $459M fund for goal-line dealmaking. Story

Pharma News

@FiercePharma: Thursday's top story: Novo Nordisk recruiting 400 U.S. sales reps as growth decelerates. Article | Follow @FiercePharma

@EricPFierce: FDA has new plan to arrest drug shortages. Its ultimate solution is for drugmakers to improve quality. Story | Follow @EricPFierce

@CarlyHFierce: Once again, Bayer's new drugs power pharma sales upward. ICYMI yesterday | Follow @CarlyHFierce

> Mylan looks to 2014 for big growth. Report

> Teva says it may have violated bribery laws around the world. More

> Vertex's Incivek unseats Celebrex as fastest drug launch ever. Story

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.